May 2013 New Drug CME/CEU Review

HOW TO TAKE THE POST-TEST: To obtain CE credit, please click here to participate in this educational activity on myCME.com.

---

Release Date: May 23, 2013

Expiration Date: May 31, 2014

Estimated Time to Complete:  1 hour

Program Description:

Clinicians should be informed and stay current about new molecular entities and new indications of drugs for use in everyday practice. This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk and clinical trials data of a broad spectrum of new agents and those that have been granted a new indication. This activity will allow these healthcare professionals to make the most up-to-date—and most appropriate—therapeutic decisions for their patients.

Activity Objectives:

After participating in this activity, clinicians should be better able to:

• List drug names, mechanisms of action, and pharmacologic properties
• Identify contraindications and precautions that may preclude or condition the drug’s use
• Outline potential adverse drug reactions, drug interactions, and necessary monitoring parameters
• Discuss route of administration, dosing schedule, and dosing formulations
• Compare therapy with other members of the same therapeutic class
• For Pharmacists Only: Provide accurate and appropriate counsel as part of the treatment team

Credits	Type	Accreditation Statement	Designation Statement
1.00	AMA PRA Category 1 Credit(s)TM	This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Haymarket Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.	The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1.00	CE for Pharmacists	Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.	Postgraduate Institute for Medicine designates this continuing education activity for 1.00 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number (UAN) 0809-9999-13-290-H01-P.

Disclosures:

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Evelyn Hermes-DeSantis, PharmD, has nothing to disclose.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following Haymarket Medical Education planners and managers, hereby state the following financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months: Nick Zittell, Editor, Alejo Miranda, and Dhara Shah, have nothing to disclose.

The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accredited Provider:

Jointly sponsored by Postgraduate Institute for Medicine and Haymarket Medical Education

         

If you have any questions relating to the accreditation of this activity, please contact [email protected].

Commercial Supporter:

There is no commercial support for this activity.